The Centers for Medicare & Medicaid Services (CMS) has informed Elevance Health of its intention to impose penalties, including a suspension of new member enrollment in the insurer's Medicare Advantage prescription drug plans, according to a document. Unless regulators determine that the relevant issues have been adequately resolved, the penalty is scheduled to take effect on March 31, 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments